Skip to content

Humacyte Inc

HUMA

Latest QuantConomy context for HUMA: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
14
Asset profile

Humacyte Inc

QuantConomy has a structured record for HUMA. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
HUMA
Name
Humacyte Inc
Coverage
3 market/data records
Sources
fmp alphavantage alpaca sec nasdaq binance
Latest signal rows

Recent signals for HUMA

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
bearish cluster
very bearish
60
Jul 7, 07:30 PM Bearish signal cluster for HUMA: 5 signals across 3 types (VOLUME, TECHNICAL, PRICE) with 80% bearish consistency [moderate signal]
net income change
very bullish
76
May 13, 12:00 AM HUMA (Q1 2026, net income): grew 56.9% (-$40.83M → -$17.62M). [sequential period basis, very bullish signal]
revenue change
very bearish
76
May 13, 12:00 AM HUMA (Q1 2026, revenue): declined 64.5% ($1.39M → $493.00K). [sequential period basis, very bearish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.

Market coverage

Market Exchange Source Asset record
HUMA NASDAQ fmp Humacyte, Inc.
HUMA NASDAQ alphavantage Humacyte Inc
HUMA NASDAQ alpaca Humacyte, Inc. Common Stock

Recent insider transactions

Buys, last 90d
2
Sells, last 90d
2
Rows
14
Date Insider Role Type Shares Price Value Filing
Jun 11, 2026 Niklason Laura E President, CEO and Director grant 80,000 4 on EDGAR
Jun 11, 2026 Wallace Max N. Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Seimetz Diane Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Constantino Michael T. Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Jones Keith Anthony Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Windham-Bannister Susan Richards Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Green Charles Bruce Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Sebelius Kathleen Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Bamforth John Philip Insider grant 80,000 4 on EDGAR
Jun 11, 2026 Brown Emery N. Insider grant 80,000 4 on EDGAR
May 19, 2026 Sebelius Kathleen Director purchase 56,818 $0.88 $50,000 4 on EDGAR
May 18, 2026 Constantino Michael T. Director purchase 11,000 $0.89 $9,840 4 on EDGAR
May 18, 2026 Parikh Shamik J Chief Medical Officer sale 45,887 $0.90 $41,147 4 on EDGAR
May 18, 2026 Sander Dale A. CFO and Chief Corp. Dev. Off sale 45,887 $0.90 $41,147 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query HUMA context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access